Saxena White P.A. is pleased to announce that on March 20, 2025, the United States District Court for the Middle District of Tennessee appointed The Arbitrage Fund, AltShares Merger Arbitrage ETF, AltShares Event-Driven ETF, iMGP Alternative Strategies Fund, and Chicago Capital Management, LP as Lead Plaintiff and Saxena White P.A. as Co-Lead Counsel in the securities class action against Revance Therapeutics, Inc.

The action alleges that, during the class period, Defendants made materially false and misleading statements and failed to disclose that Revance was in material breach of a distribution agreement with Teoxane SA, subjecting Revance to an increased risk of litigation, as well as monetary and reputational harm, and increasing the risk that Revance’s agreement to be acquired by Crown Laboratories, Inc. would be delayed and/or amended.